NEW YORK (TheStreet) -- Nu Skin
(NUS - Get Report) stock is slipping in premarket trading after second-quarter guidance came in below expectations.
Before the bell, shares had dropped 3.5% to $84.51.
The beauty products retailer said it expects revenue of around $700 million and net income of $1.25 a share over the three months to June. Analysts surveyed by Thomson Reuters had forecast $789.5 million and $1.43 a share.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
The lower guidance comes as business operations in China have resumed, following an investigation into its direct-selling practices.
"Because we are only a few days into the recommencement of promotional activities in China
, it is difficult to forecast how the business will perform," said CFO Ritch Wood in a statement.
TheStreet Ratings team rates NU SKIN ENTERPRISES as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate NU SKIN ENTERPRISES (NUS) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow."
Must Read: Warren Buffett's 10 Favorite Growth Stocks
STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
WATCH: More market update videos on TheStreet TV
| More videos from Keris Alison Lahiff
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts